Diligence memo · auto-generated · as of July 2, 2026

Zenflow, Inc.

Zenflow, Inc. looks fair against its niche peers and is active on financing cadence.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

Zenflow, Inc. operates in Medical Devices, based in SOUTH SAN FRANCISCO, CA, USA. Medical device that provides a more effective, less invasive…

Sub-sector tags: Medical Devices, medical-devices.

Capital & rounds (filed)filed

Zenflow, Inc. has raised $75M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $31M on 2017-09-12.

Most recent recorded round closed around 2024-11-01.

Valuation (modeled)modeled

Provath models Zenflow, Inc. at approximately $117M (range $44M–$196M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.73× the median modeled value of Series B Medical Devices companies in 2022–2024 (5 peers) — value vs value, same stage and era. Within the normal band (73% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 21 months.

Last raise 20 mo ago; this sector typically re-raises about every 16 months.

Raising on or ahead of the sector's normal rhythm.

The last round was 1.2× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 96% of Medical Devices peers (233 compared).

Modeled value ranks above 90% of those peers.

Closest niche peers: Proxim Diagnostics Corp, Eximis Surgical Inc., EarliTec Diagnostics, Inc., Htg Molecular Diagnostics, Inc.

Peoplefiled

10 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.